The Food Bank needs help packing quarantine food kits. Photo courtesy of Houston Food Bank

As the long lines at any local Costco suggest, the coronavirus/COVID 19 phenomenon has caused some to interpret news reports advising sensible precautions such as "wash your hands thoroughly" to mean "buy a car-full of toilet paper."

Talk of a potential quarantine has only added to the fervor, as citizens are advised to stock up on food for up to two weeks. But what of those who can't don masks and charge through sprawling stores looking for tuna packets?

The Houston Food Bank is asking that local residents assist those who do not have reserves of food in the event of service disruptions and closures. The non-profit has put out a call for volunteers to help pack essential quarantine food kits. The boxes are not yet being requested, but will be necessary in the event there is a need due to COVID-19 occurrences in their service area, according to the Food Bank.

"Hundreds of thousands of people are counting on the organization and its partners now, and this need will only heighten if the COVID-19 situation worsens," says Brian Greene, president/CEO of Houston Food Bank.

Volunteers can sign up for shifts online to help pack these boxes at the Food Bank, 535 Portwall St. Volunteer shifts run from 8 am to noon Monday–Saturday, from 6 pm to 9 pm Monday–Friday, and from 9 am to noon Sunday.

To quell any obvious concerns about safety, the Food Bank has increased the frequency of cleaning and disinfecting, especially around high-traffic areas, such as volunteer areas, elevators, meeting rooms, bathrooms, food areas.

Greene also notes that volunteers can bring much-needed items to donate and pack. The Food Bank's most-needed items include:

  • Rice
  • Pasta
  • Peanut butter
  • Canned protein
  • Soups
  • Jelly
  • Nutritious snacks
  • Canned Vegetable
  • Canned fruit
  • Hygiene items
  • Cleaning supplies: paper towels, disinfectant, bleach wipes
  • Bottled water

And, says Greene, "a little something sweet like cookies never hurt."

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.